Li Guang Ma

Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.